Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure

Autor: Bruinsma, SM, Roobol, MJ, Carroll, PR, Auvinen, A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______4853::08560e57a1682da194d65f0d07403518
https://trepo.tuni.fi/handle/10024/102764

Een internationale studie naar de praktijk van palliatieve sedatie

Autor: Bruinsma, SM, Rietjens, Judith, Janssens, R, Zuylen, Lia, van der Heide, Agnes

Publikováno v: Nederlands-Vlaams Tijdschrift voor Palliatieve Zorg, 11(1), 22-26

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=narcis______::8a94655c3bd69369f5e0377e1f1223a4
https://pure.eur.nl/en/publications/6f577a98-989e-4b26-9180-d4734e813c72

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Consistent Biopsy Quality and Gleason Grading Within the Global Active Surveillance Global Action Plan 3 Initiative: A Prerequisite for Future Studies.

Autor: van der Kwast TH; Department of Pathology, Princess Margaret Cancer Center, University Health Network, Toronto, Ontario, Canada. Electronic address: theodorus.vanderkwast@uhn.ca., Helleman J; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Nieboer D; Department of Urology, Erasmus MC, Rotterdam, The Netherlands; Department of Public Health, Erasmus MC, Rotterdam, The Netherlands., Bruinsma SM; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Roobol MJ; Department of Urology, Erasmus MC, Rotterdam, The Netherlands., Trock B; Johns Hopkins University, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Ehdaie B; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Carroll P; University of California San Francisco, San Francisco, CA, USA., Filson C; Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA., Kim J; MD Anderson Cancer Centre, Houston, TX, USA., Logothetis C; MD Anderson Cancer Centre, Houston, TX, USA., Morgan T; University of Michigan and Michigan Urological Surgery Improvement Collaborative, Michigan, USA., Klotz L; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Pickles T; University of British Columbia, BC Cancer Agency, Vancouver, Canada., Hyndman E; University of Calgary, Southern Alberta Institute of Urology, Calgary, Canada., Moore CM; University College London and University College London Hospital Trust, London, UK., Gnanapragasam V; University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Van Hemelrijck M; King's College London, London, UK; Guy's and St Thomas' NHS Foundation Trust, London, UK., Dasgupta P; Guy's and St Thomas' NHS Foundation Trust, London, UK., Bangma C; Erasmus Medical Center, Rotterdam, The Netherlands., Roobol M; Erasmus Medical Center, Rotterdam, The Netherlands., Villers A; Lille University Hospital Center, Lille, France., Rannikko A; Helsinki University and Helsinki University Hospital, Helsinki, Finland., Valdagni R; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1 and Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Perry A; University College Dublin, Dublin, Ireland., Hugosson J; Sahlgrenska University Hospital, Göteborg, Sweden., Rubio-Briones J; Instituto Valenciano de Oncología, Valencia, Spain., Bjartell A; Skåne University Hospital, Malmö, Sweden., Hefermehl L; Kan-tonsspital Baden, Baden, Switzerland., Shiong LL; Singapore General Hospital, Singapore, Singapore., Frydenberg M; Monash Health; Monash University, Melbourne, Australia., Kakehi Y; Kagawa University Faculty of Medicine, Kagawa, Japan., Chung BH; Gangnam Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea., van der Kwast T; Princess Margaret Cancer Centre, Toronto, Canada., Obbink H; Royal Philips, Eindhoven, The Netherlands., van der Linden W; Royal Philips, Eindhoven, The Netherlands., Hulsen T; Royal Philips, Eindhoven, The Netherlands., de Jonge C; Royal Philips, Eindhoven, The Netherlands., Kattan M; Cleveland Clinic, Cleveland, OH, USA., Xinge J; Cleveland Clinic, Cleveland, OH, USA., Muir K; University of Manchester, Manchester, UK., Lophatananon A; University of Manchester, Manchester, UK., Fahey M; Epworth HealthCare, Melbourne, Australia., Steyerberg E; Erasmus Medical Center, Rotterdam, The Netherlands., Nieboer D; Erasmus Medical Center, Rotterdam, The Netherlands., Zhang L; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., Guo W; Johns Hopkins University, The James Buchanan Brady Urological Institute, Baltimore, MD, USA., Benfante N; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Cowan J; University of California San Francisco, San Francisco, CA, USA., Patil D; Emory University School of Medicine, Winship Cancer Institute, Atlanta, GA, USA., Tolosa E; MD Anderson Cancer Centre, Houston, TX, USA., Kim TK; University of Michigan and Michigan Urological Surgery Improvement Collaborative, Ann Arbor, MI, USA., Mamedov A; University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada., LaPointe V; University of British Columbia, BC Cancer Agency, Vancouver, Canada., Crump T; University of Calgary, Southern Alberta Institute of Urology, Calgary, Canada., Kimberly-Duffell J; University of Cambridge and Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Santaolalla A; King's College London, London, UK., Nieboer D; Erasmus Medical Center, Rotterdam, The Netherlands., Olivier JT; Lille University Hospital Center, Lille, France., Rancati T; Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., Ahlgren H; Sahlgrenska University Hospital, Göteborg, Sweden., Mascarós J; Instituto Valenciano de Oncología, Valencia, Spain., Löfgren A; Skåne University Hospital, Malmö, Sweden., Lehmann K; Kantonsspital Baden, Baden, Switzerland., Lin CH; Monash University and Epworth HealthCare, Melbourne, Australia., Hirama H; Kagawa University, Kagawa, Japan., Lee KS; Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea., Jenster G; Erasmus MC, Rotterdam, The Netherlands., Auvinen A; University of Tampere, Tampere, Finland., Bjartell A; Instituto Valenciano de Oncología, Valencia, Spain., Haider M; University of Toronto, Toronto, Canada., van Bochove K; The Hyve B.V. Utrecht, Utrecht, The Netherlands., Carter B; Johns Hopkins University, Baltimore, MD, USA., Gledhill S; Movember Foundation, Melbourne, Australia., Buzza M; Movember Foundation, Melbourne, Australia., Bangma C; Erasmus Medical Center, Rotterdam, The Netherlands., Roobol M; Erasmus Medical Center, Rotterdam, The Netherlands., Bruinsma S; Erasmus Medical Center, Rotterdam, The Netherlands., Helleman J; Erasmus Medical Center, Rotterdam, The Netherlands.

Publikováno v: European urology oncology [Eur Urol Oncol] 2019 May; Vol. 2 (3), pp. 333-336. Date of Electronic Publication: 2018 Sep 13.

Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.

Autor: Bruinsma SM; Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands., Roobol MJ; Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands., Carroll PR; University of California, San Francisco, 550 16th Street, Department of Urology, 6th Floor, Mailbox Code 1695, San Francisco, California 94143, USA., Klotz L; University of Toronto, Sunnybrook Health Sciences Centre, 2075 Bayview Avenue, #MG 408, Toronto, Ontario M4N 3M5, Canada., Pickles T; University of British Columbia, Department of Radiotherapy &Developmental Radiotherapeutics, Radiation Oncology, BC Cancer Agency, 600 West 10th Avenue Vancouver, British Columbia, V6R 2T9, Canada., Moore CM; University College London and University College London Hospitals Trust, 4th Floor, Rockefeller Building, 74 Huntley Street, London, WC1E 6AU, UK., Gnanapragasam VJ; Academic Urology Group, Department of Surgery and Oncology, University of Cambridge, Box 279 (S4), Cambridge Biomedical Campus, Cambridge CB2 0QQ, UK., Villers A; Department of Urology, Hôpital Huriez, Place de Verdun, Centre Hospitalier Regional Universitaire, 59037 Lille, France., Rannikko A; Helsinki University and Helsinki University Hospital, Department of Urology, PL340, 00029 HUS, Helsinki, Finland., Valdagni R; Department of Oncology and Hemato-oncology, Università degli Studi di Milano, Radiation Oncology 1, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian 1 - 20133 Milano, Italy., Frydenberg M; Department of Urology, Monash Health; Department of Surgery, Faculty of Medicine, Monash University, 322 Glenferrie Road, Malvern, Melbourne 3144, Victoria, Australia., Kakehi Y; Department of Urology, Kagawa University Faculty of Medicine, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa 761-0793, Japan., Filson CP; Department of Urology, Winship Cancer Center, Emory University School of Medicine, 1365 Clifton Road NE, Suite B1400, Atlanta, Georgia, USA., Bangma CH; Department of Urology, Erasmus Medical Center, Wytemaweg 80, 3015 CN Rotterdam, Netherlands.

Publikováno v: Nature reviews. Urology [Nat Rev Urol] 2017 May; Vol. 14 (5), pp. 312-322. Date of Electronic Publication: 2017 Mar 14.